Berry Genomics Co.,Ltd (SHE:000710)
12.28
+0.07 (0.57%)
Feb 4, 2026, 3:04 PM CST
Berry Genomics Co.,Ltd Market Cap
Berry Genomics Co.,Ltd has a market cap or net worth of 4.34 billion as of February 4, 2026. Its market cap has increased by 49.76% in one year.
Market Cap
4.34B
Enterprise Value
4.34B
Revenue
941.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.28
Market Cap Chart
Since June 20, 2017, Berry Genomics Co.,Ltd's market cap has decreased from 24.43B to 4.34B, a decrease of -82.23%. That is a compound annual growth rate of -18.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 4.32B | 8.15% |
| Dec 31, 2025 | 3.99B | 33.61% |
| Dec 31, 2024 | 2.99B | -26.65% |
| Dec 29, 2023 | 4.07B | 0.96% |
| Dec 30, 2022 | 4.03B | -40.71% |
| Dec 31, 2021 | 6.80B | -49.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 8.46B |
| Beijing Strong Biotechnologies,Inc. | 7.74B |
| Maccura Biotechnology Co.Ltd | 7.34B |
| Cowealth Medical China | 7.08B |
| SMO ClinPlus CO.,LTD. | 5.51B |
| Guangdong Hybribio Biotech | 4.80B |
| Thalys Medical Technology Group | 4.56B |
| Shanghai Labway Clinical Laboratory | 4.48B |